AKT1 and gastric cancer: Previous research in our laboratory demonstrated that CDH1-null cells have increased sensitivity to allosteric AKT inhibitors (ARQ-092, MK2206) compared to CDH1-expressing cells (in isogenic mammary and gastric cancer cell line pairs) [25].